Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hong Kong Investigates Maker Of Diuretic Found To Have Fungus

This article was originally published in PharmAsia News

Executive Summary

Hong Kong's Department of Health is investigating drug maker Vickmans Laboratories after its diuretic Diurex (frusemide) was found to contain a fungus. Vickman was ordered to halt production and review its management process and procedures as the government collects evidence. The case could lead to a license suspension for the Hong Kong company if it is found to have allowed the aspergillus fungus in its drug. The department believes the fungus developed because the granules were held too long before being placed into tablets. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071428

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel